
Maximum toxicity to tumors.
Dosimetry-Guided Radiopharmaceutical Therapy (DG-RPT)
For cancer patients, personalized radiopharmaceutical therapy (RPT) can mean increased tumor response, a higher quality of life and longer overall survival.
RPT provides an attractive alternative to chemotherapy, but one-size-fits-all dosing methods can result in under- or over-treatment. Dosimetry-guidance can unlock the full potential of RPT for patients.
Maximum toxicity to tumors.
Reduced damage to critical structures.
Improved survival.
Fewer side effects.
GPU-Accelerated RPT Dose Assessment
Torch™ simplifies the otherwise complex task of analyzing a patient’s nuclear medicine scans to develop a personalized assessment, including estimates of patient-specific pharmacokinetics and calculation of dose to the patient’s tumors and critical structures.
© 2022 Voximetry Incorporated – All Rights Reserved.